Nevertheless, although approaches targeted to ACCs have been explored and many small chemical inhibitors against ACC1 and/or ACC2 have been developed, their efficacy as potential drugs to cancer treatment remains to be further investigated. The gene discussed is ACACB; the disease is cancer.